Psoriasis and Psoriatic Arthritis in the US--New Report Available from Piribo

Share Article

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has just added to its collection a key market report on Psoriasis and Psoriatic Arthritis in the US.

Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has just added to its collection a key market report on Psoriasis and Psoriatic Arthritis in the US.

“Psoriasis and Psoriatic Arthritis - A Strategic Analysis of the Market in the United States” (http://www.piribo.com/search/results.html?k=kal089&x=0&y=0) focuses on the applications of current and advanced therapeutics to the treatment of psoriasis and psoriatic arthritis, the options they present, and the progress that is being made in these fields. The major market effects of new therapeutics, with the potential of a breakthrough drug always a possibility, are expected to be seen over the next ten years. The technology trends selected in conjunction with the growing interest in psoriasis and its treatment present the most informative picture of advances in psoriasis and psoriatic arthritis therapeutics and the markets that result.

The report’s market analysis includes:

  • extensive discussion of the pathology of the multiple forms of the disease
  • thorough examination of the epidemiology in the United States segmented by severity and projected to 2016
  • comprehensive analysis of the total available market and serviceable available market for psoriasis (by severity) and psoriatic arthritis through 2016
  • monthly cost per patient forecasts for psoriasis (by severity) and psoriatic arthritis through 2016

In depth company profiles of major competitors and a meticulous review of the expert conclusions and strategic implications for competitors serious about winning in the psoriasis therapeutics field round out this systematic analysis.

The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including immunologists, dermatologists, rheumatologists, pathologists, research scientists, business development managers and marketing managers.

Content in brief

Chapter One: Executive Summary

Chapter Two: Pathology and Epidemiology

Chapter Three: Current Therapies

Chapter Four: Market Analysis

Chapter Five: Company Profiles

Chapter Six: Conclusions and Strategic Implications

“Psoriasis and Psoriatic Arthritis - A Strategic Analysis of the Market in the United States” is available in PDF format from Piribo. For more information, go to: http://www.piribo.com/publications/diseases_conditions/psoriasis_psoriatic_arthritis_market.html

About Piribo.

Piribo is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,800 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Brendt Sheen
Visit website